See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

ReliOn at Wal-Mart

Bob Guest

ReliOn at Wal-Mart

Easy to Use Insulin Delivery Patch

Anna Tucker

Easy to Use Insulin Delivery Patch

Metformin Archives

Diabetes and Metformin

Page 2
Metformin Better Than Insulin for Gestational Diabetes?

Insulin may not be the best first line of defense for women who develop gestational diabetes, according to the results of a new study.

Comments 0 comments - Sep 4, 2013 - * * * * *

Maryland Researchers Enrolling Type 2 Patients in Long-Term Drug Study

BALTIMORE-Researchers at the University of Maryland School of Medicine are enrolling patients with type 2 diabetes into an NIH-funded clinical trial to evaluate the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication.

Comments 0 comments - Aug 18, 2013 - * * * * *

My Pal Paul and the Type 2 Jitters

My down-the-street neighbor, Paul (not his real name), has type 2. We often stop to talk about our numbers, our latest visits to the endocrinologist, and our concerns.

Comments 0 comments - Jul 12, 2013 - * * * * *

Metformin Bests Glipizide in Reducing Cardio Events

A Chinese research study of diabetes patients with coronary heart disease concludes that metformin is more effective than glipizide in reducing the risk of major cardiovascular events, such as stroke and heart attack.

Comments 0 comments - Jan 20, 2013 - * * * * *

Riding on Insulin

Professional snowboarder Sean Busby started competing at age 14 and began training for the Winter Olympics at 16. But in 2004, at age 19, Sean's troubling bouts of thirst and weariness were revealed as symptoms of type 1 diabetes.

Comments 0 comments - Jan 8, 2013 - * * * * *

Metformin May Boost Cancer Survival, Curb Depression

Like aspirin, metformin is one of those drugs that over the years keeps proving itself beneficial in ways it wasn't originally intended to be.

Comments 0 comments - Dec 16, 2012 - * * * * *

Lilly Says Its New Injectible Outperforms Three Popular Diabetes Drugs

Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.

Comments 0 comments - Nov 20, 2012 - * * * * *

Lilly Says Its New Injectible Outperforms 3 Popular Diabetes Drugs

Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.

Comments 0 comments - Nov 5, 2012 - * * * * *

Mayo Clinic Says Simple Lifestyle Changes Can Forestall Type 2

The Mayo Clinic Health Letter for August 2012 has published three lifestyle changes that could stave off the progression of prediabetes to full-blown type 2 diabetes. The list isn't new, but its periodic reiteration indicates that healthcare researchers and providers have settled on a simple prescription for staying diabetes-free.

Comments 1 comment - Sep 4, 2012 - * * * * *

US Sale of Generic Actos Gets FDA Nod

The Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type 2 diabetes. Actos, originally developed and trademarked by Takeda Pharmaceuticals, works by decreasing insulin resistance in type 2 patients. The prescription drug, which belongs to the class of drugs known as thiazolidinediones (TZDs), has enjoyed great commercial success in the United States since its introduction in 1999, posting estimated sales last year of $2.7 billion.

Comments 0 comments - Aug 27, 2012 - * * * * *

Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.